These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25497488)

  • 21. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles.
    Geiser M; Casaulta M; Kupferschmid B; Schulz H; Semmler-Behnke M; Kreyling W
    Am J Respir Cell Mol Biol; 2008 Mar; 38(3):371-6. PubMed ID: 17947511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.
    Wanakule P; Liu GW; Fleury AT; Roy K
    J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
    J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages.
    Hirota K; Hasegawa T; Nakajima T; Makino K; Terada H
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):293-8. PubMed ID: 21700434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
    Hirota K; Hasegawa T; Hinata H; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H
    J Control Release; 2007 May; 119(1):69-76. PubMed ID: 17335927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats.
    Parikh R; Patel L; Dalwadi S
    Drug Deliv; 2014 Sep; 21(6):406-11. PubMed ID: 24215141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation.
    Warheit DB; Hansen JF; Yuen IS; Kelly DP; Snajdr SI; Hartsky MA
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):10-22. PubMed ID: 9221819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation.
    Park JH; Jin HE; Kim DD; Chung SJ; Shim WS; Shim CK
    Int J Pharm; 2013 Jan; 441(1-2):562-9. PubMed ID: 23142421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo targeting of alveolar macrophages via RAFT-based glycopolymers.
    Song EH; Manganiello MJ; Chow YH; Ghosn B; Convertine AJ; Stayton PS; Schnapp LM; Ratner DM
    Biomaterials; 2012 Oct; 33(28):6889-97. PubMed ID: 22770567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of nanoparticulate systems for macrophage targeting.
    Chellat F; Merhi Y; Moreau A; Yahia L
    Biomaterials; 2005 Dec; 26(35):7260-75. PubMed ID: 16023200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F; Lefoulon F
    Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalation of particulate lead oxide disrupts pulmonary macrophage-mediated functions important for host defense and tumor surveillance in the lung.
    Zelikoff JT; Parsons E; Schlesinger RB
    Environ Res; 1993 Aug; 62(2):207-22. PubMed ID: 8393781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Tissue Delivery of Virus-Like Particles Mediated by Macrolide Antibiotics.
    Crooke SN; Schimer J; Raji I; Wu B; Oyelere AK; Finn MG
    Mol Pharm; 2019 Jul; 16(7):2947-2955. PubMed ID: 31244221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of hexagonal polymeric micelles in macrophage phagocytosis.
    Tsai HC; Chang CH; Chiu YC; Lin SY; Lin CP; Hsiue GH
    Macromol Rapid Commun; 2011 Sep; 32(18):1442-6. PubMed ID: 21732463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification.
    Chono S; Tanino T; Seki T; Morimoto K
    J Pharm Pharmacol; 2007 Jan; 59(1):75-80. PubMed ID: 17227623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage uptake of Janus particles depends upon Janus balance.
    Gao Y; Yu Y
    Langmuir; 2015 Mar; 31(9):2833-8. PubMed ID: 25674706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Drug Delivery Systems for Lung Macrophages.
    Costa A; Sarmento B; Seabra V
    Curr Drug Targets; 2015; 16(14):1565-81. PubMed ID: 25395103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.